Roseanne D. Dobkin

Rutgers, The State University of New Jersey — United States

Medicine · Health Sciences

30h-index3.2kcitations95works8.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(58), Neurological disorders and treatments(23), Autism Spectrum Disorder Research(19), Restless Legs Syndrome Research(9), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes(8)

Publications93 total

Telepsychotherapy Improves Health-Related Quality of Life in Parkinson’s Disease
American Journal of Geriatric Psychiatry·2025
Clinical and imaging characteristics of Parkinson’s disease with negative alpha-synuclein seed amplification assay
2025Open Access
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Annals of Neurology·2025· 1 citedOpen Access
Overcoming challenges to successful recruitment of individuals at the earliest stages of disease: An example from Parkinson’s disease research
2025Open Access
Development and Validation of the Parkinson’s Disease Specific Anxiety Inventory (PDSAI)
Journal of Geriatric Psychiatry and Neurology·2025· 1 citedOpen Access
Parkinson’s Disease Specific Anxiety Inventory
PsycTESTS Dataset·2025
<i>LRRK2</i> -associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
Brain Communications·2025· 8 citedOpen Access
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia
2024Open Access
“Reply: Improving Insight and Application: A Commentary on the Link between Initial Depression and Anxiety and Long‐Term Health Outcomes in Parkinson's Disease Patients”
Movement Disorders Clinical Practice·2024Open Access
Long-Term Dementia Risk in Parkinson Disease
Neurology·2024· 55 citedOpen Access
Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease
Movement Disorders Clinical Practice·2024· 9 citedOpen Access
Defining the Importance of Minor Hallucinations in Parkinson's Disease
Movement Disorders·2024· 1 cited
If You Don’t Ask, You Won’t Know: Inclusive Recruitment Strategies for the Parkinson Progression Markers Initiative (PPMI)
Parkinsonism & Related Disorders·2024
Real or imagined: We need a new scale for psychosis in Parkinson's disease
Parkinsonism & Related Disorders·2024· 5 cited
Reward and Punishment Learning as Predictors of Cognitive Behavioral Therapy Response in Parkinson’s Disease Comorbid with Clinical Depression
Journal of Geriatric Psychiatry and Neurology·2023· 1 cited
Social Control and Health Behaviors Among Individuals Living with Parkinson’s Disease: A Pilot Study
International Journal of Behavioral Medicine·2023· 1 cited
Recruiting for Parkinson's disease risk: Successful engagement tactics to screen for hyposmia in undiagnosed individuals
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
Minor Phenomena in Parkinson’s Disease–Prevalence, Associations, and Risk of Developing Psychosis
Journal of Geriatric Psychiatry and Neurology·2023· 9 cited
0908 Multi-modal Recruitment of Individuals with REM Sleep Behavior Disorder into a Longitudinal Prodromal Parkinson’s Study
SLEEP·2023Open Access
Risk of Psychosis among those with Parkinson’s disease with and without Minor Hallucinations (P6-11.010)
Neurology·2023
page 1 of 5Next →

Frequent Co-authors

Matthew Menza(26), Michael A. Gara(18), Humberto Marín(13), Karina Bienfait(13), Lesley A. Allen(12), Margery H. Mark(9), Daniel Weintraub(7), Allison Dicke(6), Alejandro Interian(6), Jill Harkavy‐Friedman(5), N. Dissanayaka(5), Chelsea Caspell‐Garcia(5), Lana M. Chahine(5), Jade Tiu(4), Nabila Dahodwala(4), Sarah Mann(4), Gregory M. Pontone(4), Ethan Brown(4), Kenneth Marek(4), Monica Korell(4)